Skip to main content
. Author manuscript; available in PMC: 2013 May 1.
Published in final edited form as: Ther Drug Monit. 2001 Aug;23(4):316–331. doi: 10.1097/00007691-200108000-00002

TABLE 3.

Perchlorate dose-response in humans exposed therapeutically, occupationally, in clinical studies, or environmentally via drinking water

Effect/endpoint Daily dose Body-weight adjusted
daily dose*
Fatal hemotoxicity (aplastic anemia) 1000–2000 mg 15–30 mg/kg
Nonfatal hemotoxicity (blood dyscrasias,
  including agranulocytosis)
600–1000 mg 8.5–14 mg/kg
400 mg agranulocytosis 5.7 mg/kg
Therapeutic effect range for amiodarone treatment 1000 mg start followed by 100 mg 12.8 mg/kg then 1.4 mg/kg
Pharmacological effect range (normalization of
  tyroid function in hyperthyroid patients)
200–1000 mg 2.8–14 mg/kg
Calculated safe occupational average (BMDL) 50 mg 0.7 mg/kg
Demonstrated safe occupational average Per shift average Per shift average
2.5 mg1 0.036 mg/kg1
34 mg2 0.48 mg/kg2
No-effect level for TSH elevation in newborns
  (environmental level 5–25 ppb)
Amount in 2L drinking water 2.9 µg/kg3
200 µg3 0.29 µg/kg4
20 µg4
*

Based on a 70-kg adult.

No-effect level for tests of thyroid function in occupationally exposed.

Exposed in utero via maternal consumption of drinking water. TSH, thyroid-stimulating hormone.